Skip to NavigationSkip to content

News

HLB have announced that its anticancer drug candidate, rivoceranib, has been awarded Orphan Drug Status by the FDA. HLB is conducting a Phase III...
The UK government will roll out Merck’s COVID-19 antiviral pill, molnupiravir, through drug trial later this month. In early November, the UK became...
The FDA has declined to grant Emergency Use Authorisation for NRx Pharmaceuticals’ therapy, Zyesami® (aviptadil), in the treatment of critical COVID-...
Pfizer UK and Entia’s home blood monitoring device for breast cancer patients is in late-stage development, with regulatory approvals expected for...
Republican governors are expected to sue in response to the Biden administration’s requirement that US employers ensure workers are tested or...
A new study has shown that combining two existing cancer drugs for leukaemia and melanoma could offer a promising future for children with incurable...
Imperial College London have said that COVID-19 rates in England rose to its highest level on record in October. 
WHO has approved Bharat Biotech’s Covaxin COVID-19 vaccine for emergency use in individuals aged 18 years and above.
UNION therapeutics have received a Fast Track designation from the FDA for their oral orismilast for the treatment of moderate to severe atopic...
The human papillomavirus (HPV) vaccine is cutting cervical cancer rates by 87% in women who were offered the vaccine between the ages of 12 and 13 (...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches